Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carl Lavie and Fabian Sanchis-Gomar.
Carl Lavie
Connection Strength
5.222
Fabian Sanchis-Gomar
  1. Why is COVID-19 especially impacting the African American population? Ann Med. 2020 11; 52(7):331-333.
    View in: PubMed
    Score: 0.898
  2. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? Eur Heart J. 2020 07 01; 41(32):3092-3093.
    View in: PubMed
    Score: 0.890
  3. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection. Ann Intern Med. 2021 06; 174(6):885-886.
    View in: PubMed
    Score: 0.237
  4. In Reply - Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization. Mayo Clin Proc. 2021 03; 96(3):823-824.
    View in: PubMed
    Score: 0.231
  5. CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients. Acad Radiol. 2021 03; 28(3):440-441.
    View in: PubMed
    Score: 0.231
  6. Fit Is It in COVID-19, Future Pandemics, and Overall Healthy Living. Mayo Clin Proc. 2021 01; 96(1):7-9.
    View in: PubMed
    Score: 0.229
  7. Cardiac Injury in COVID-19-Echoing Prognostication. J Am Coll Cardiol. 2020 11 03; 76(18):2056-2059.
    View in: PubMed
    Score: 0.228
  8. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
    View in: PubMed
    Score: 0.228
  9. Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? Am J Cardiovasc Drugs. 2020 Oct; 20(5):413-418.
    View in: PubMed
    Score: 0.226
  10. In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
    View in: PubMed
    Score: 0.226
  11. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
    View in: PubMed
    Score: 0.222
  12. COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
    View in: PubMed
    Score: 0.221
  13. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
    View in: PubMed
    Score: 0.221
  14. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
    View in: PubMed
    Score: 0.221
  15. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
    View in: PubMed
    Score: 0.220
  16. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
    View in: PubMed
    Score: 0.219
  17. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May - Jun; 63(3):390-391.
    View in: PubMed
    Score: 0.218
  18. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.